Thread by @Biotech2k1

My Exit Strategy Updated:

Not at my trading laptop so all are estimates. I plan to fade all rallies in biotech back to old high as value for the $XBI is only $112.

Pathways:

$BPMC 3.34% will keep my 2.02% paid core
$MRTX 3.34% will keep my 2.02% paid core
$TPTX 3.34% will keep my 2.02% paid core
$SDGR sell all
$RVMD sell all
$ERAS sell all
$RLAY sell all
$RTPX sell all

Protein Degraders:

$ARVN sell all
$KYMR 1.35% will keep my .67% core
$CCCC 1.35% will keep my .67% core
$GLUE 2.02% will keep my .67% core

CRISPR:

$CRBU sell all its only company in the massive bubble space I still own. I would sell it if we retest the highs for the $XBI.

Cell Therapies:

$IPSC 1.35% will keep my .67% core
$TIL 1.35% will keep my .67 core
$CABA 1.35% will keep my .67% core
$SANA 1.35% will keep my .67% core

Delivery:

$GBIO sell all
$FDMT sell all
$SANA moved to cell therapies

That would be me circling my wagons around my core position until the bubble pops as I see any realistic value on the $XBI of $112 or less. I don't mind stopping trading for a few years until the collapse. Plenty of cool science stuff to do while I wait out this blow off top.

I am keeping my watch lists active so I have a shopping list ready for when that next collapse comes like it did last spring of the pandemic. There is always the next disaster to create a better buying opportunity.